CLINICAL EVALUATION OF KHADIRARISHTA, KAISHORE GUGGULU AND GANDHAKADI MALHAR IN THE MANAGEMENT OF VICHARCHIKA (ECZEMA)

Central Council for Research in Ayurvedic sciences0 个研究点目标入组 120 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•Known cases of eczema (based on Hanifin and Rajka Criteria for Atopic Dermatitis/ Atopic Eczema) and willing and able to participate in the study

•Patients with Status Eczematous condition.
•Patients with poorly controlled Hypertension ( >160/100 mmHg)
•Patients with uncontrolled Diabetes Mellitus having HbA1C > 8%
•Patients on medication with corticosteroids, phototherapy, biologics, antidepressants and any other drugs that may have an influence on the outcome of the study.
•Patients who have history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months
•Symptomatic patients with clinical evidence of Heart failure
•Known cases of HIV and AIDS.
•Known cases of malignancy
•Patient taking participation in any other clinical trial.
•Women who are planning for conception / pregnant or lactating.
•Patients with concurrent serious hepatic disorders (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease (COPD)
•H/o hypersensitivity to any of the trial drugs or their ingredients
•Patients who have completed participation in any other clinical trial during the past three months
•Any other condition which the Investigator thinks may jeopardize the study

发起方